SCHEMBL13360863

SCHEMBL13360863

CCC1CC1(C=O)NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
MAPK1 P28482 1/20 0.38
CTSK P43235 3/20 0.35
ALDH1A1 P00352 2/20 0.33
CACNA1H O95180 1/20 0.33
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
EPHX1 P07099 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA7 P43166 1/20 0.32
CA14 Q9ULX7 1/20 0.32
APLNR P35414 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
GHSR Q92847 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13415253 1.00 KMT2A (0.38) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL15928515 0.82 EPHX2 (0.34) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL15928447 0.82 EPHX2 (0.34) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL15928475 0.82 EPHX2 (0.34) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL15928504 0.82 EPHX2 (0.34) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL22080250 0.81 MEN1 (0.42) KMT2AMEN1MAPK1CTSKCACNA1H
SCHEMBL13360948 0.80 KMT2A (0.41) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL4383932 0.77 KMT2A (0.37) KMT2AMEN1MAPK1CTSKALDH1A1
SCHEMBL13302345 0.76 MEN1 (0.38) KMT2AMEN1MAPK1CTSKCACNA1H
SCHEMBL8372247 0.76 MEN1 (0.38) KMT2AMEN1MAPK1CTSKCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE41356-E1 Hepatitis C inhibitor tri-peptides BOEHRINGER INGELHEIM CANADA LTD. (CA) 2010-05-25 US disclosed
EP-2028186-A2 Hepatitis C inhibitor tri-peptides BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2009-02-25 EP disclosed
US-RE40525-E1 Hepatitis C inhibitor tri-peptides BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2008-09-30 US disclosed